Health British Columbia

Second PSMA PET Scan Finds Hidden Prostate Cancer in 56% of Patients

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be too small or too faint to appear yet. New research suggests that repeating a PSMA PET scan late…

Second PSMA PET Scan Finds Hidden Prostate Cancer in 56% of Patients
Text to audio Audio version available

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be too small or too faint to appear yet. New research suggests that repeating a PSMA PET scan later can reveal cancer that was missed the first time. Among patients with rising prostate-specific antigen (PSA) [...]

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be too small or too faint to appear yet. New research suggests that repeating a PSMA PET scan later can reveal cancer that was missed the first time.

Among patients with rising prostate-specific antigen (PSA) levels but no visible disease on their initial scan, a second test detected cancer in 56 percent of cases. The results changed treatment plans for nearly half of the patients. The findings were published in the July issue of The

Source and reference

Journal of Nuclear Medicine. Prostate cancer can return after surgery or radiation therapy without immediately producing symptoms or a tumor that doctors can see. Instead, the first warning may be a rising PSA level in the blood, a situation known as biochemical recurrence. The increase suggests that prostate cells remain somewhere in the body, but it does not reveal their location. This can make treatment decisions difficult. Doctors may need to determine whether the cancer is confined to the area where it began, has reached nearby lymph nodes, or has spread to distant organs. Each pattern can require a different strategy. PSMA PET imaging is designed to help solve that problem. A radioactive tracer attaches to prostate-specific membrane antigen, a protein often found at high levels on prostate cancer cells. The scan then highlights areas where the tracer accumulates, potentially...

Read original source
Published
Jul 17, 2026
Updated
Jul 17, 2026
Source
Scitechdaily
Category
Health
Read time
3 min
Key facts

Key facts

SectionHealth
Open
SourceScitechdaily
Open
PublishedJul 17, 2026
UpdatedJul 17, 2026

Why this matters locally

This health story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.

Local impact

BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.

Timeline

PublishedJul 17, 2026, 5:21 PMThis story was published by BC Post.
ImportedJul 17, 2026, 6:01 PMThe item entered the BC Post source pipeline.
Transparency

Source and credit

BC Post may summarize, organize, and add local context for reader clarity. Original reporting remains with the listed publisher.

Scitechdaily Published Jul 17, 2026 Imported Jul 17, 2026
Read Original Source
Scitechdaily Jul 17, 2026
Read Original Source